Table 2 Comparison of the severity of AP in the HTG group and NHTG group

Atlanta classification (n, %)

0.019

 MAP

273 (45.7)

187 (43.2)

86 (52.1)

 MSAP

294 (49.2)

218 (50.3)

76 (46.1)

 SAP

31 (5.2)

28 (6.5)

3 (1.8)

OF, (n, %)

 POF

31 (5.2)

28 (6.5)

3 (1.8)

0.022

 Persistent respiratory failure

25 (4.2)

23 (5.3)

2 (1.2)

0.022

 Persistent renal failure

14 (2.3)

13 (3.0)

1 (0.6)

0.127

 Persistent heart failure

1 (0.2)

1 (0.2)

0 (0)

1.000

 TOF

18 (3.0)

13 (3.0)

5 (3.0)

0.968

Local Complications (n, %)

 APFC (n, %)

294 (49.2)

226 (52.2)

68 (41.20)

0.016

 ANC (n, %)

26 (4.3)

18 (4.2)

8 (4.8)

0.711

 PPC (n, %)

13 (2.2)

10 (2.3)

3 (1.8)

0.713

 WON (n, %)

3 (0.5)

3 (0.7)

0 (0)

0.565

 IPN (n, %)

2 (0.3)

2 (0.5)

0 (0)

0.382

 MCTSI

4 (2–6)

4 (2–6)

4 (2–6)

0.296

Laboratory indicators

 TG

4.5 (1.7–15.5)

8.7 (3.5–21.7)

1.0 (0.7–1.4)

 < 0.001

 LDH

270.5 (208.8–431.1)

270.0 (205.8–429.3)

271.0 (211.5–436.5)

0.717

 HDL-C

0.9 (0.7–1.2)

0.8 (0.6–1.1)

1.2 (0.9–1.5)

0.000

 WBC

12.2 (9.4–15.1)

12.5 (10.0–15.5)

10.7 (7.9–13.9)

0.003

 BUN

4.9 (3.7–6.3)

4.9 (3.8–6.3)

5.1 (3.5–6.5)

0.052

 CRE

72.0 (60.0–84.0)

72.0 (60.0–84.8)

72.0 (59.8–82.0)

0.110

 Ca²⁺

2.2 (2.1–2.3)

2.2 (2.1–2.3)

2.2 (2.1–2.3)

0.891